AtonRa Partners - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.

Quarter-by-quarter ownership
AtonRa Partners ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q1 2022$863,000
-38.5%
13,505
+3.0%
0.47%
-3.9%
Q4 2021$1,404,000
+11.6%
13,111
+7.1%
0.49%
+16.2%
Q3 2021$1,258,000
+25.5%
12,238
+7.4%
0.42%
+14.4%
Q2 2021$1,002,000
+18.2%
11,397
+30.7%
0.37%
-2.9%
Q1 2021$848,000
+12.3%
8,723
+29.6%
0.38%
+2.2%
Q4 2020$755,0006,7320.37%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 379,090$19,037,90017.25%
DAFNA Capital Management LLC 249,521$12,530,9453.90%
Rock Springs Capital Management LP 2,685,294$134,855,4653.61%
Casdin Capital, LLC 371,378$18,650,6032.06%
Novo Holdings A/S 525,000$26,365,5001.95%
CHI Advisors LLC 92,888$4,664,8351.85%
SECTORAL ASSET MANAGEMENT INC 165,890$8,330,9961.62%
Avidity Partners Management LP 751,600$37,745,3521.52%
EMERALD ADVISERS, LLC 607,037$30,485,3931.48%
EMERALD MUTUAL FUND ADVISERS TRUST 464,321$23,318,2011.41%
View complete list of BLUEPRINT MEDICINES CORP shareholders